期刊
ADVANCED DRUG DELIVERY REVIEWS
卷 57, 期 14, 页码 2047-2052出版社
ELSEVIER
DOI: 10.1016/j.addr.2005.09.006
关键词
age-related macular degeneration; microparticulates; nanoparticulates; drug delivery; pharmacotherapy; choroidal neovascularization
Objectives: Pharmacotherapeutics has begun to play an increasingly important role in the management of patients with neovascular age-related macular degeneration (AMD). Because micro- and nano-particulates are currently being evaluated as a potential drug-delivery option for AMD patients, the purpose of this analysis was to describe how micro- and nanoparticulates have been used experimentally and what their potential clinical applications may be. Findings: Micro- and nano-particulates have been used primarily on a pre-clinical basis as new drug-delivery devices in experimental models of neovascular AMD. Conclusions: It is likely that micro- and nano-particulates will become an important component of targeted clinical pharmacotherapeutics in patients with neovascular AMD. (c) 2005 Published by Elsevier B.V.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据